Novavax (NVAX) volatility elevated into Phase III RSV vaccine data
Get Alerts NVAX Hot Sheet
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) August call option implied volatility is at 102, September is at 159; compared to its 52-week range of 61 to 140 into the expected release of Q2 results on August 9 and Phase III RSV vaccine data in Q3.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing (BA) April weekly option implied volatility into quarter results
- Alphabet (GOOG) April weekly option implied volatility into quarter results
- Otis Worldwide (OTIS) May option implied volatility into quarter results
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!